Regulation of adiponectin receptor expression in human liver and a hepatocyte cell line

被引:45
作者
Shimizu, Akiko
Takamura, Toshinari [1 ]
Matsuzawa, Naoto
Nakamura, Seiji
Nabemoto, Satoko
Takeshita, Yurnie
Misu, Hirofumi
Kurita, Seiichiro
Sakurai, Masaru
Yokoyama, Masayoshi
Zen, Yoh
Sasaki, Motoko
Nakanuma, Yasuni
Kaneko, Shuichi
机构
[1] Kanazawa Univ, Dept Dis Control & Homeostasis, Grad Sch Med Sci, Kanazawa, Ishikawa 9208641, Japan
[2] Kanazawa Univ, Dept Human Pathol, Grad Sch Med Sci, Kanazawa, Ishikawa 9208641, Japan
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2007年 / 56卷 / 11期
关键词
D O I
10.1016/j.metabol.2007.06.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) is closely associated with obesity. An adipocyte-derived hormone, adiponectin, may play a role in the pathophysiolo-gy of NAFLD through insulin-sensitizing and antifibrotic effects. We found that hepatic expression of adiponectin receptor AdipoR2, but not AdipoR1, was down-regulated in 14 patients with NAFLD compared with 7 patients with a normal liver (P <.05). To investigate the significance of the adiponectin system in obesity and NAFLD, we examined the regulation of AdipoR2 expression in a nonmalienant human hepatocyte cell line, the THLE-5b cells. Insulin down-regulated the levels of AdipoR2 messenger RNA (mRNA) and protein, whereas an adipocyrokine, turnor necrosis factor g., up-regulated them. A thiazolidinedione, pioglitazone, up-regulated the expression of AdipoR2 mRNA and protein in THLE-5b cells. The AdipoR2 mRNA level was decreased in fatty THLE-5b cells induced by coincubating with fatty acids. These findings suggest that down-regulation of AdipoR2 in the liver caused by hypermsulinernia and steatosis may play a role in the development of NAFLD. (C) 2007 Elsevier hic. All rights reserved.
引用
收藏
页码:1478 / 1485
页数:8
相关论文
共 41 条
[21]   Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet [J].
Kawaguchi, K ;
Sakaida, I ;
Tsuchiya, M ;
Omori, K ;
Takami, T ;
Okita, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 315 (01) :187-195
[22]   α-Fetoprotein-producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis [J].
Kawai, HF ;
Kaneko, S ;
Honda, M ;
Shirota, Y ;
Kobayashi, K .
HEPATOLOGY, 2001, 33 (03) :676-691
[23]   Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance [J].
Kelley, DE ;
McKolanis, TM ;
Hegazi, RAF ;
Kuller, LH ;
Kalhan, SC .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 285 (04) :E906-E916
[24]   PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein [J].
Maeda, N ;
Takahashi, M ;
Funahashi, T ;
Kihara, S ;
Nishizawa, H ;
Kishida, K ;
Nagaretani, H ;
Matsuda, M ;
Komuro, R ;
Ouchi, N ;
Kuriyama, H ;
Hotta, K ;
Nakamura, T ;
Shimomura, I ;
Matsuzawa, Y .
DIABETES, 2001, 50 (09) :2094-2099
[25]   Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome [J].
Marchesini, G ;
Bugianesi, E ;
Forlani, G ;
Cerrelli, F ;
Lenzi, M ;
Manini, R ;
Natale, S ;
Vanni, E ;
Villanova, N ;
Melchionda, N ;
Rizzetto, M .
HEPATOLOGY, 2003, 37 (04) :917-923
[26]   HOMEOSTASIS MODEL ASSESSMENT - INSULIN RESISTANCE AND BETA-CELL FUNCTION FROM FASTING PLASMA-GLUCOSE AND INSULIN CONCENTRATIONS IN MAN [J].
MATTHEWS, DR ;
HOSKER, JP ;
RUDENSKI, AS ;
NAYLOR, BA ;
TREACHER, DF ;
TURNER, RC .
DIABETOLOGIA, 1985, 28 (07) :412-419
[27]   Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone [J].
Neuschwander-Tetri, BA ;
Brunt, EM ;
Wehmeier, KR ;
Oliver, D ;
Bacon, BR .
HEPATOLOGY, 2003, 38 (04) :1008-1017
[28]   Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference [J].
Neuschwander-Tetri, BA ;
Caldwell, SH .
HEPATOLOGY, 2003, 37 (05) :1202-1219
[29]   Enhanced GLUT2 gene expression in an oleic acid-induced in vitro fatty liver model [J].
Okamoto, Y ;
Tanaka, S ;
Haga, Y .
HEPATOLOGY RESEARCH, 2002, 23 (02) :138-144
[30]   Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model [J].
Ota, T ;
Takamura, T ;
Ando, H ;
Nohara, E ;
Yamashita, H ;
Kobayashi, K .
DIABETOLOGIA, 2003, 46 (06) :843-851